Rapamycin prolongs survival of murine recipients of fully allogeneic donor grafts when administered during the graft-versus-host disease process.
Blazar
B R
BR
Department of Pediatrics, University of Minnesota Hospital and Clinic, Minneapolis 55455.
Taylor
P A
PA
Sehgal
S N
SN
Vallera
D A
DA
D000818:Animals; D006085:Graft Survival / Q000187:drug effects*; D006086:Graft vs Host Disease / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D011090:Polyenes / Q000494:pharmacology*; D020123:Sirolimus; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus